How can the discovery of novel pharmaceuticals for diseases, old and new, be better, faster and cheaper? The pat answer is, of course, research. But, given that more than 80% of all scientists who have ever lived are alive today, why are there only 10-20 new drugs approved each year? Why does it cost $1 billion and take 15 years to get each one to market? And why are there fewer and fewer global pharmaceutical companies charging us more and more for our prescription drugs?
For Advertisers
Translational Disconnect
Bioscience innovation is in crisis. What can we do about it?
(continued >>)
To continue reading this full article, you must be a subscriber to The Scientist.
You are only a few minutes away from unlimited access.
If you already have an online subscription, please Log-In Now.
New to The Scientist? Register to get access to a selection of our content, interactive features and useful tools free without a subscription.
New to The Scientist? Register to get access to a selection of our content, interactive features and useful tools free without a subscription.
Subscribe to The Scientist to get unlimited access to our premium content
Get unlimited access to this article and over 20 years of The Scientist archives. You won’t miss a word – all for as little as $4.95. Subscribe now.The Scientist offers site licenses to institutions and organizations. Recommend us to your librarian and get online access through your place or work or study.